Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Tsutsumi, T. Ohtsuka, Yasuhisa Mori, M. Fujino, T. Yasui, S. Aishima, S. Takahata, Masafumi Nakamura, Tetsuhide Ito, Masao Tanaka (2012)
Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal productionJournal of Gastroenterology, 47
S. Grobmyer, F. Pieracci, P. Allen, M. Brennan, D. Jaques (2007)
Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system.Journal of the American College of Surgeons, 204 3
Charles Yeo, Bernadette Wang, G. Anthone, John Cameron (1993)
Surgical experience with pancreatic islet-cell tumors.Archives of surgery, 128 10
C. Yeo, J. Cameron, T. Sohn, K. Lillemoe, H. Pitt, M. Talamini, R. Hruban, S. Ord, P. Sauter, J. Coleman, Marianna Zahurak, L. Grochow, R. Abrams (1997)
Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.Annals of surgery, 226 3
J. Hlavsa, V. Procházka, Z. Kala, M. Man, T. Andrasina, M. Číhalová, V. Valek, M. Crha, I. Svobodová, Lucie Urbanova (2011)
[Radiofrequency ablation of pancreatic neuroendocrine tumor].Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 24 3
P. Tomassetti, D. Campana, L. Piscitelli, R. Casadei, D. Santini, Francesca Nori, A. Morselli-Labate, R. Pezzilli, R. Corinaldesi (2005)
Endocrine pancreatic tumors: factors correlated with survival.Annals of oncology : official journal of the European Society for Medical Oncology, 16 11
K. Bilimoria, M. Talamonti, J. Tomlinson, A. Stewart, D. Winchester, C. Ko, D. Bentrem (2008)
Prognostic Score Predicting Survival After Resection of Pancreatic Neuroendocrine Tumors: Analysis of 3851 PatientsAnnals of Surgery, 247
C. Ferrone, Laura Tang, J. Tomlinson, M. Gonen, S. Hochwald, M. Brennan, D. Klimstra, P. Allen (2007)
Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 35
W. Burns, B. Edil (2012)
Neuroendocrine Pancreatic Tumors: Guidelines for Management and UpdateCurrent Treatment Options in Oncology, 13
R. Bettini, S. Partelli, L. Boninsegna, P. Capelli, S. Crippa, P. Pederzoli, A. Scarpa, M. Falconi (2011)
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.Surgery, 150 1
M. Fesinmeyer, M. Austin, Christopher Li, A. Roos, D. Bowen (2005)
Differences in Survival by Histologic Type of Pancreatic CancerCancer Epidemiology Biomarkers & Prevention, 14
E. Lermite, D. Sommacale, T. Piardi, J. Arnaud, A. Sauvanet, C. Dejong, P. Pessaux (2013)
Complications after pancreatic resection: diagnosis, prevention and management.Clinics and research in hepatology and gastroenterology, 37 3
M. Falconi, U. Plöckinger, D. Kwekkeboom, R. Manfredi, M. Körner, L. Kvols, U. Pape, J. Ricke, P. Goretzki, S. Wildi, T. Steinmüller, K. Öberg, J. Scoazec (2007)
Well-Differentiated Pancreatic Nonfunctioning Tumors/CarcinomaNeuroendocrinology, 84
Milan (2012)
Neuroendocrine tumors of the pancreas.Curr Opin Oncol, 24
F. Berends, M. Cuesta, G. Kazemier, C. Eijck, W. Herder, J. Muiswinkel, H. Bruining, H. Bonjer (2000)
Laparoscopic detection and resection of insulinomas.Surgery, 128 3
L. Fernández‐Cruz, V. Molina, Rodrigo Vallejos, E. Chavarría, M. López-Boado, J. Ferrer (2012)
Outcome after laparoscopic enucleation for non-functional neuroendocrine pancreatic tumours.HPB : the official journal of the International Hepato Pancreato Biliary Association, 14 3
Kevork Kazanjian, H. Reber, O. Hines (2006)
Resection of pancreatic neuroendocrine tumors: results of 70 cases.Archives of surgery, 141 8
N. Jarufe, C. Coldham, T. Oruğ, A. Mayer, D. Mirza, J. Buckels, S. Bramhall (2005)
Neuroendocrine Tumours of the Pancreas: Predictors of Survival after Surgical TreatmentDigestive Surgery, 22
Laureano Fernández-Cruz, Miguel Herrera, A. Sáenz, J. Pantoja, E. Astudillo, M. Sierra (2001)
Laparoscopic pancreatic surgery in patients with neuroendocrine tumours: indications and limits.Best practice & research. Clinical endocrinology & metabolism, 15 2
Y. Nieuwenhove, S. Vandaele, B. Beeck, G. Delvaux (2003)
Neuroendocrine tumors of the pancreasSurgical Endoscopy And Other Interventional Techniques, 17
M. Kulke, A. Benson, E. Bergsland, J. Berlin, L. Blaszkowsky, M. Choti, O. Clark, G. Doherty, James Eason, L. Emerson, P. Engstrom, W. Goldner, M. Heslin, F. Kandeel, P. Kunz, B. Kuvshinoff, J. Moley, V. Pillarisetty, L. Saltz, D. Schteingart, M. Shah, S. Shibata, J. Strosberg, J. Vauthey, R. White, James Yao, Deborah Freedman-Cass, Mary Dwyer (2012)
Neuroendocrine tumors.Journal of the National Comprehensive Cancer Network : JNCCN, 10 6
G. Klöppel (2011)
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.Endocrine-related cancer, 18 Suppl 1
R. Bettini, L. Boninsegna, William Mantovani, P. Capelli, Claudio Bassi, P. Pederzoli, G. Fave, F. Panzuto, Aldo Scarpa, Massimo Falconi (2008)
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours.Annals of oncology : official journal of the European Society for Medical Oncology, 19 5
I. Madeira, B. Terris, M. Voss, A. Denys, A. Sauvanet, J. Fléjou, V. Vilgrain, J. Belghiti, P. Bernades, P. Ruszniewski (1998)
Prognostic factors in patients with endocrine tumours of the duodenopancreatic areaGut, 43
N. Hamilton, Ta-Chiang Liu, Antonino Cavatiao, K. Mawad, Ling Chen, S. Strasberg, D. Linehan, D. Cao, W. Hawkins (2012)
Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms.Surgery, 152 1
A. Haynes, V. Deshpande, T. Ingkakul, P. Vagefi, J. Szymonifka, S. Thayer, C. Ferrone, J. Wargo, A. Warshaw, C. Castillo (2011)
Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.Archives of surgery, 146 5
James Yao, Manal Hassan, A. Phan, Cecile Dagohoy, C. Leary, J. Mares, E. Abdalla, J. Fleming, J. Vauthey, A. Rashid, Douglas Evans (2008)
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 18
G. Phan, C. Yeo, R. Hruban, Keith Littemoe, H. Pitt, J. Cameron (1998)
Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: Review of 125 patientsJournal of Gastrointestinal Surgery, 2
P. Vagefi, O. Razo, V. Deshpande, D. McGrath, G. Lauwers, S. Thayer, A. Warshaw, C. Castillo (2007)
Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.Archives of surgery, 142 4
J. Parekh, Sam Wang, E. Bergsland, A. Venook, R. Warren, Grace Kim, E. Nakakura (2012)
Lymph Node Sampling Rates and Predictors of Nodal Metastasis in Pancreatic Neuroendocrine Tumor Resections: The UCSF Experience With 149 PatientsPancreas, 41
Joseph DiNorcia, Minna Lee, P. Reavey, J. Genkinger, James Lee, B. Schrope, J. Chabot, J. Allendorf (2010)
One Hundred Thirty Resections for Pancreatic Neuroendocrine Tumor: Evaluating the Impact of Minimally Invasive and Parenchyma-Sparing TechniquesJournal of Gastrointestinal Surgery, 14
N. Hamilton, M. Porembka, F. Johnston, F. Gao, S. Strasberg, D. Linehan, W. Hawkins (2012)
Mesh Reinforcement of Pancreatic Transection Decreases Incidence of Pancreatic Occlusion Failure for Left Pancreatectomy: A Single-Blinded, Randomized Controlled TrialAnnals of Surgery, 255
K. Lillemoe, S. Kaushal, J. Cameron, T. Sohn, H. Pitt, C. Yeo (1999)
Distal pancreatectomy: indications and outcomes in 235 patients.Annals of surgery, 229 5
C. Castillo, D. Rattner, A. Warshaw (1995)
Standards for pancreatic resection in the 1990s.Archives of surgery, 130 3
J. Sarmiento, M. Farnell, F. Que, D. Nagorney (2002)
Pancreaticoduodenectomy for Islet Cell Tumors of the Head of the Pancreas: Long-term Survival AnalysisWorld Journal of Surgery, 26
M. Amin, S. Edge, F. Greene, D. Byrd, R. Brookland, M. Washington, J. Gershenwald, C. Compton, K. Hess, D. Sullivan, J. Jessup, J. Brierley, L. Gaspar, R. Schilsky, C. Balch, D. Winchester, Elliot Asare, M. Madera, Donna Gress, L. Meyer (2002)
AJCC Cancer Staging Manual
S. Strasberg, J. Drebin, N. Mokadam, D. Green, Karen Jones, Justis Ehlers, D. Linehan (2002)
Prospective trial of a blood supply-based technique of pancreaticojejunostomy: effect on anastomotic failure in the Whipple procedure.Journal of the American College of Surgeons, 194 6
J. Franko, Wentao Feng, L. Yip, E. Genovese, A. Moser (2010)
Non-functional Neuroendocrine Carcinoma of the Pancreas: Incidence, Tumor Biology, and Outcomes in 2,158 PatientsJournal of Gastrointestinal Surgery, 14
Shota Tatsumoto, Y. Kodama, Y. Sakurai, T. Shinohara, A. Katanuma, H. Maguchi (2013)
Pancreatic neuroendocrine neoplasm: correlation between computed tomography enhancement patterns and prognostic factors of surgical and endoscopic ultrasound-guided fine-needle aspiration biopsy specimensAbdominal Imaging, 38
(1992)
[Neuroendocrine tumors].La Revue du praticien, 42 7
FEATURE Regional Lymphadenectomy Is Indicated in the Surgical Treatment of Pancreatic Neuroendocrine Tumors (PNETs) ∗ ∗ ∗ Yassar M. Hashim, MD, Kathryn M. Trinkaus, PhD,† David C. Linehan, MD, Steven S. Strasberg, MD, ∗ ∗ Ryan C. Fields, MD, Dengfeng Cao, MD, PhD,‡ and William G. Hawkins, MD clinical outcomes of PNETs vary greatly, and although the majority Objective: To explore the prognostic importance and preoperative predictors are relatively benign, slow growing, and noninfiltrative, a subset is of lymph node metastasis in an effort to guide surgical decision making in aggressive, rapidly metastasizing, and locally invasive. PNETs can patients with pancreatic neuroendocrine tumors (PNETs). also be divided into functional and nonfunctional on the basis of Background: PNETs are uncommon, and the natural history of the disease hypersecretion of biologically active hormones, resulting in clinical is not well described. As a result, there remains controversy regarding the syndromes. The natural history of PNETs is consequently highly optimal management of regional lymph nodes during resection of the primary variable, with the majority having a more favorable outcome and tumor. longer overall survival (OS) after surgical resection than pancreatic Methods: A retrospective review of a prospectively maintained database of 5 6 adenocarcinoma.
Annals of Surgery – Wolters Kluwer Health
Published: Feb 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.